Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Diabetic Neuropathy

The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for diabetic peripheral neuropathy in its Worcester, MA facility. Diabetic neuropathy is a common complication of diabetes in which nerves are damaged as a result of high blood sugar levels. Symptoms... - July 31, 2010

Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Psoriatic Arthritis

The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for psoriatic arthritis in its Worcester, MA facility. Subjects who enroll in a clinical trial are carefully selected from a list of inclusion and exclusion criteria designed to ensure safety for the... - July 31, 2010

Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Rheumatoid Arthritis Studies

The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for rheumatoid arthritis in their Worcester, MA facility. Subjects who enroll in a clinical trial are carefully selected from a list of inclusion and exclusion criteria designed to ensure safety for... - June 25, 2010

Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Fibromyalgia Studies

The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for fibromyalgia in their Worcester, MA facility. Subjects who enroll in a clinical trial are carefully selected from a list of inclusion and exclusion criteria designed to ensure safety for the... - June 18, 2010

Press Releases 1 - 4 of 4